AB
AI Biotechnology LLC cut its LTGO stake below 5%
AI Biotechnology LLC reported owning 4.8% of Latigo Biotherapeutics, Inc. (LTGO) (3,193,565 shares) in a Schedule 13G filed Nov 6, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 6, 2026
- Source
- Schedule 13G